ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy.

Mingming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.